Compression for preventing recurrence of venous ulcers

Nelson, E Andrea; Bell-Syer, Sally EM

doi:10.1002/14651858.cd002303.pub3

Cited by 91 publications

(77 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Treatment and/or lifestyle changes may be required to break the cycle of recurring ulceration. Surgery or endovascular procedures are sometimes warranted to treat venous disorders (Mosti, 2012) and compression therapy (Nelson & Bell-Syer, 2014) found to significantly reduce the likelihood of ulceration, but concordance is often difficult to achieve (Harding, 2016;Moffatt, Kommala, Dourdin, & Choe, 2009).…”

Section: Introductionmentioning

confidence: 99%

Reflection on the cause and avoidance of recurrent venous leg ulcers: An interpretive descriptive approach

Stewart

Edwards

Finlayson

2018

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Reflection on the cause and avoidance of recurrent venous leg ulcers: An interpretive descriptive approach

Stewart

Edwards

Finlayson

2018

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

“…Compression therapy is widely accepted as the gold standard for the management of venous leg ulcers (VLUs), as stated in many countries' clinical guidelines (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11). Compression can dramatically increase the healing rates of VLUs as well as reduce their risk of recurrence (12,13). However, despite this acceptance, compression therapy is underused across numerous geographies (14).…”

Section: Introductionmentioning

confidence: 99%

Challenging passivity in venous leg ulcer care – the ABC model of management

Harding

2016

International Wound Journal

View full text Add to dashboard Cite

The under-utilisation of compression for venous leg ulcer (VLU) management translates into lost opportunities to heal wounds, improve patients' quality of life and maximise health care system efficiency. Although compression therapy is considered gold standard according to clinical guidelines, lack of clinician knowledge, unclear referral pathways, local unavailability of compression and patient unwillingness to receive compression, amongst other reasons, mean many candidates for compression do not receive appropriate treatment. This article presents a solution in the form of the 'ABC model of VLU management, a simplified approach that challenges passivity in the current approach to VLU treatment and supports wider adoption of appropriate compression therapy systems.

show abstract

“…Among the aforementioned device forms, the ECSs are the most widely applied to treat all stages of CVI, largely because of its low profile, cost-effectiveness, and sustained mobile pressure delivery (Cullum, Nelson, Fletcher, & Sheldon, 2001;Nelson, Bell-Syer, Cullum, & Webster, 2000). Four compression classes that adhere to the RAL-GZ 387/1 standard are commonly employed, that is, light (Class I: 18-21 mmHg), medium (Class II: 23-32 mmHg), strong (Class III: 34-46 mmHg), and very strong (Class IV: 49+ mmHg) (Mosti & Partsch, 2011), as indicated by ankle skin pressure.…”

Section: Polymer-based Therapeutic Compression Materials (Devices)mentioning

confidence: 99%

Therapeutic compression materials and wound dressings for chronic venous insufficiency: A comprehensive review

Liu

Lao

2019

J Biomed Mater Res

View full text Add to dashboard Cite

Chronic venous insufficiency (CVI) is a common disorder worldwide. Related pathophysiological mechanisms reportedly involve venous pooling and reduced venous return, leading to heaviness, aching, itchiness, tiredness, varicosities, pigmentation, and even lower limb ulceration. Approaches adopted to manage CVI at various stages of clinical‐etiology‐anatomy‐pathophysiology include compression therapy, pharmacological treatment, ultrasound treatment, surgery, electrical or wireless microcurrent stimulation, and pulsed electromagnetic treatment. Among these, polymer‐based therapeutic compression materials and wound dressings play increasingly key roles in treating all stages of CVI because of their unique physical, mechanical, chemical, and biological functions. However, the characteristics, working mechanisms, and effectiveness of these CVI treatment materials are not comprehensively understood. The present systematic review examines the structures, properties, types, and applications of various polymer‐based compression materials and wound dressings used in prophylaxis and treatment of CVI. Existing problems, limitations, and future trends of CVI treatment materials are also discussed. This review could contribute to the design and application of new functional polymer materials and dressings to enhance the efficiency of CVI treatments, thereby facilitating patients' self‐care ability and long‐term health improvement.

show abstract

Compression for preventing recurrence of venous ulcers

Cited by 91 publications

References 20 publications

Reflection on the cause and avoidance of recurrent venous leg ulcers: An interpretive descriptive approach

Reflection on the cause and avoidance of recurrent venous leg ulcers: An interpretive descriptive approach

Challenging passivity in venous leg ulcer care – the ABC model of management

Therapeutic compression materials and wound dressings for chronic venous insufficiency: A comprehensive review

Contact Info

Product

Resources

About